Dabrafenib Induced Pancreatitis: A Rare Event During RAI- Refractory Treatment of Metastatic Papillary Thyroid Cancer

MLA

David G. McFadden, et al. “Dabrafenib Induced Pancreatitis: A Rare Event During RAI- Refractory Treatment of Metastatic Papillary Thyroid Cancer.” Journal of the Endocrine Society, vol. 5, May 2021, pp. A888–89. EBSCOhost, https://doi.org/10.1210/jendso/bvab048.1814.

APA

David G. McFadden, Khary Edwards, & Sarimar N Agosto Salgado. (2021). Dabrafenib Induced Pancreatitis: A Rare Event During RAI- Refractory Treatment of Metastatic Papillary Thyroid Cancer. Journal of the Endocrine Society, 5, A888–A889. https://doi.org/10.1210/jendso/bvab048.1814

Chicago

David G. McFadden, Khary Edwards, and Sarimar N Agosto Salgado. 2021. “Dabrafenib Induced Pancreatitis: A Rare Event During RAI- Refractory Treatment of Metastatic Papillary Thyroid Cancer.” Journal of the Endocrine Society 5 (May): A888–89. doi:10.1210/jendso/bvab048.1814.